The economic vaccine jabs
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
The economic vaccine jabs

Panorama

Jyoti Rahman
03 October, 2021, 10:45 am
Last modified: 03 October, 2021, 12:24 pm

Related News

  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement
  • Incepta Pharma abandons Covid vaccine plan
  • World renowned Vaccinologist Professor Dame Sarah Gilbert visits Incepta Pharma

The economic vaccine jabs

Regardless of what is discussed at the International Monetary Fund and World Bank annual meetings, which are scheduled to take place in Washington, DC this October, macroeconomic stability and better-functioning markets are the two doses of economic vaccine jabs we need

Jyoti Rahman
03 October, 2021, 10:45 am
Last modified: 03 October, 2021, 12:24 pm
Jyoti Rahman. Illustration: TBS
Jyoti Rahman. Illustration: TBS

Every October, finance ministers and central bank governors from around the world gather for the annual meetings of the International Monetary Fund and the World Bank. The meetings, and accompanying seminars, roundtables, workshops, lectures and so on, are also attended by senior officials responsible for economic development, civil society participants, academics and public intellectuals, corporate representatives, and, of course, protesters. Washington, DC is the usual venue, but once every three years, the meetings take place elsewhere. Marrakesh is scheduled to host them in 2022. 

With the delta variant still rampant around the world, this year's meetings will be a hybrid of the physical and virtual. Also casting a pall over the proceedings will be the so-called 'doing business scandal', with a blistering call by the Economist magazine for the IMF chief Kristalina Georgieva to quit. 

In 2003, the World Bank started publishing an index that rated and ranked countries based on their regulatory and legal environments, ease of business start-ups, financing, infrastructure, and other business climate measures. The 'Doing Business' indicators were taken seriously by multinationals, development practitioners, and governments around the world. For example, in 2017, China's prime minister expressed concern that his country was falling behind.

Following that, China's scores improved. And now, an independent report claims that the report was tampered with by the Bank's then-CEO Georgieva under "undue pressure" from China. At the time of writing this, the future of the IMF chief hangs in the balance, while the World Bank had already cancelled the annual Doing Business Report. 

The Doing Business indicators reflected one plank of the so-called Washington Consensus, the other plank being macroeconomic stability through prudent monetary and fiscal policies. The idea was that countries with sound public finances, well-run banks, liberal trade and foreign investment regimes, and rule of law would see more investment, innovation, economic growth, jobs, and income over time. 

These policy prescriptions reflect the mainstream, neoclassical economics that dominates international financial institutions, as well as finance ministries and central banks in major economies.

According to Kevin and Robin Grier of Texas Tech University, the Consensus worked along the lines expected by its proponents. Looking at 141 countries between 1970 and 2015, the authors identified 49 cases of policy reforms as prescribed by the Consensus. 

They found that countries adopting Washington Consensus policies, on average and after accounting for other factors, grew by 2.1-2.9 percentage points faster in the post-reform five years (and 1-1.9 percentage points faster over ten years) than countries that had not. 

The authors used the Economic Freedom of the World Index by the Fraser Institute, a Canadian think tank, to identify the countries that adopted Consensus prescriptions. In this index, countries are given scores between 1 and 10. The index comprises five elements: the size of government and taxation, private property and the rule of law, sound money, trade regulation and tariffs, regulation of business, labour and capital markets. The higher the score, the more in line with the Consensus a country is. 

From this, a simplistic assertion would be that liberalised economies with deregulated markets and privatised industries would perform better. A more nuanced interpretation is that a country with a government that can finance its budgets and enforce the rule of law and a well-regulated private sector (including banks) that is globally competitive is more likely to be resilient to adverse shocks. 

Seen from this perspective, the Griers' finding is that the countries that did not adopt the Washington Consensus are likely to grow slower than those that did. Seen in this light, the Consensus is like a vaccine that makes one more resilient to diseases, as opposed to increasing one's fitness or stamina. 

The authors identify reform cases as those countries experiencing a one-point jump in five years, with the higher score sustained for the following decade. Bangladesh just misses out on making the cut — the country's score increased by 0.99 in the five years to 2000. Over the two previous decades, the score had been steadily rising. This trend stopped after 2000, and Bangladesh's score has actually declined since 2009 (Chart 1).

Bangladesh's performance in the Economic Freedom of the World Index over the years.
Bangladesh's performance in the Economic Freedom of the World Index over the years.

That is, if the authors' calculations are taken literally, Bangladesh would have grown much faster if the pre-2000s policy trends had continued over the last two decades. 

One can quibble about this or the weights and calculations behind Bangladesh's score in the index for a given year. But taking a step back, let us ask whether the country's banks, financial markets, and various specific sectors were better regulated in the 2010s or 1990s? In which decade did we see more scandals? In which decade were the courts more trusted? 

An honest introspection on any of these questions would lead to the very unsettling conclusion that Bangladesh has not done as well as might have been expected at the turn of the century. Regardless of what is discussed in Washington, D.C. this October, macroeconomic stability and better-functioning markets are the two doses of economic vaccine jabs we need. 

Unfortunately, the chart above does not inspire much confidence about the chances of Bangladesh getting the jabs.


Jyoti Rahman is an applied macroeconomist. His analyses are available at www.jrahman.substack.com 

Features / Top News

Vaccine / Vaccine administration / Vaccine availability / covid-19 vaccine / Coronavirus Vaccine / On the other hand / economic freedom / Economic Freedom Index

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A man stands in front of collapsed buildings following an earthquake in Kahramanmaras, Turkey February 6, 2023. Ihlas News Agency (IHA) via REUTERS ATTENTION EDITORS - THIS PICTURE WAS PROVIDED BY A THIRD PARTY. NO RESALES. NO ARCHIVES. TURKEY OUT. NO COMMERCIAL OR EDITORIAL SALES IN TURKEY.
    Deaths exceed 2,600 as catastrophic quakes ravage Turkey, Syria
  • 30% cos see double-digit growth even in hard times
    30% cos see double-digit growth even in hard times
  • Govt borrowing from commercial banks surges
    Govt borrowing from commercial banks surges

MOST VIEWED

  • Mohammad Zaved Akhtar/TBS Sketch
    Unilever CEO warns of tough 9-10 months ahead
  • Illustration: TBS
    Decoding Monetary Policy Statement 2023: Was there any better alternative?
  • Why Pakistan is struggling to get another IMF bailout
    Why Pakistan is struggling to get another IMF bailout
  • Photo: Courtesy
    From 'Made in Bangladesh' to 'Designed in Bangladesh'
  • The megaproject Rooppur Nuclear Power Plant has a debt of Tk90,474 crore. Photo: Courtesy
    Projects funded with debt need to be selected prudently, and implemented timely
  • Google must adjust to a world where content is increasingly generated by AI. Photo: Bloomberg
    Google will join the AI wars, pitting LaMDA against ChatGPT

Related News

  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement
  • Incepta Pharma abandons Covid vaccine plan
  • World renowned Vaccinologist Professor Dame Sarah Gilbert visits Incepta Pharma

Features

Photo: Collected

Get your partner a lovely present this Valentine's Day

17h | Brands
Pottery Wheel Craft Kit: A creative outlet for little hands

Pottery Wheel Craft Kit: A creative outlet for little hands

16h | Brands
Say it with Colours

Say it with Colours

1d | Mode
Photo: Courtesy

From 'Made in Bangladesh' to 'Designed in Bangladesh'

1d | Panorama

More Videos from TBS

Who will survive? Adani or Hindenburg?

Who will survive? Adani or Hindenburg?

7h | TBS Stories
James Gunn’s 8-10-year plan for the DC Universe

James Gunn’s 8-10-year plan for the DC Universe

7h | TBS Entertainment
LC issues lead to severe shortage of surgical equipment

LC issues lead to severe shortage of surgical equipment

10h | TBS Insight
Stage plays are going on in the digital age

Stage plays are going on in the digital age

15h | TBS Stories

Most Read

1
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

2
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

3
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

4
Fund cut as Dhaka's fast-track transit projects on slow spending lane
Infrastructure

Fund cut as Dhaka's fast-track transit projects on slow spending lane

5
Photo: Collected
Startups

ShopUp secures $30m debt financing to boost expansion, supply chain

6
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net